Your browser doesn't support javascript.
loading
Effect of change in hepato-renal function and cardiac rehabilitation on mortality in patients with heart failure.
Noda, Takumi; Kamiya, Kentaro; Hamazaki, Nobuaki; Nozaki, Kohei; Uchida, Shota; Ueno, Kensuke; Miki, Takashi; Hotta, Kazuki; Maekawa, Emi; Terada, Tasuku; Reed, Jennifer L; Yamaoka-Tojo, Minako; Matsunaga, Atsuhiko; Ako, Junya.
Afiliação
  • Noda T; Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan; Department of Cardiovascular Rehabilitation, National Cerebral and Cardiovascular Center, Suita, Japan.
  • Kamiya K; Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan; Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan. Electronic address: k-kamiya@kitasato-u.ac.jp.
  • Hamazaki N; Department of Rehabilitation, Kitasato University Hospital, Sagamihara, Japan.
  • Nozaki K; Department of Rehabilitation, Kitasato University Hospital, Sagamihara, Japan.
  • Uchida S; Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.
  • Ueno K; Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.
  • Miki T; Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.
  • Hotta K; Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan; Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.
  • Maekawa E; Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
  • Terada T; Exercise Physiology and Cardiovascular Health Lab, Division of Cardiac Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Canada; School of Life Sciences, Physiology, Pharmacology and Neuroscience, University of Nottingham, Nottingham, UK.
  • Reed JL; Exercise Physiology and Cardiovascular Health Lab, Division of Cardiac Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Canada; School of Human Kinetics, Faculty of Health Science
  • Yamaoka-Tojo M; Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan; Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.
  • Matsunaga A; Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan; Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.
  • Ako J; Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
J Cardiol ; 2024 Jun 23.
Article em En | MEDLINE | ID: mdl-38917873
ABSTRACT

BACKGROUND:

Patients with heart failure (HF) often suffer from hepato-renal dysfunction. The associations between hepato-renal function changes and mortality remain unclear. Further, the effect of cardiac rehabilitation (CR) on mortality and motor functions in patients with HF and hepato-renal dysfunction requires investigation.

METHODS:

We reviewed 2522 patients with HF (63.2 % male; median age 74 years). The association between changes in hepato-renal function assessed by the Model for End-stage Liver Disease eXcluding INR (MELD-XI) score and mortality was examined. The association of CR participation with mortality and physical functions was investigated in patients with HF with decreased, unchanged, and increased MELD-XI scores.

RESULTS:

During the follow-up period, 519 (20.6 %) patients died. Worsened MELD-XI score was independently associated with all-cause death [adjusted hazard ratio (aHR) 1.099; 95 % confidence interval (CI) 1.061-1.138; p < 0.001]. CR participation was associated with low mortality, even in the increased MELD-XI score group (aHR 0.498; 95 % CI 0.333-0.745; p < 0.001). Trajectory of the MELD-XI score was not associated with physical function changes. There were no time by MELD-XI score interaction effects on handgrip strength (p = 0.084), leg strength (p = 0.082), walking speed (p = 0.583), and 6-min walking distance (p = 0.833) in patients participating in outpatient CR.

CONCLUSIONS:

Hepato-renal dysfunction predicts high mortality. CR participation may be helpful for a better prognosis of patients with HF and hepato-renal dysfunction.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Cardiol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Cardiol Ano de publicação: 2024 Tipo de documento: Article